Shopping Cart
- Remove All
- Your shopping cart is currently empty
BML-278 is a SIRT1 activator with an EC150 of 1 μM. It increases H3K9 methylation and inhibits H3K9 acetylation in parental and maternal prokaryotes, improving early embryonic development. BML-278 induces cell cycle arrest at the G1/S phase in primary human mesenchymal stromal cells, delaying senescence. It also reduces microtubule protein acetylation in U937 cells and increases mitochondrial density in mouse C2C12 myoblasts.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $58 | In Stock | |
10 mg | $91 | In Stock | |
25 mg | $166 | In Stock | |
50 mg | $249 | In Stock | |
100 mg | $336 | In Stock | |
500 mg | $740 | In Stock |
Description | BML-278 is a SIRT1 activator with an EC150 of 1 μM. It increases H3K9 methylation and inhibits H3K9 acetylation in parental and maternal prokaryotes, improving early embryonic development. BML-278 induces cell cycle arrest at the G1/S phase in primary human mesenchymal stromal cells, delaying senescence. It also reduces microtubule protein acetylation in U937 cells and increases mitochondrial density in mouse C2C12 myoblasts. |
Targets&IC50 | SIRT1:1 μM(EC50) |
Alias | BML278, BML 278 |
Molecular Weight | 391.46 |
Formula | C24H25NO4 |
Cas No. | 120533-76-8 |
Smiles | CCOC(=O)C1=CN(Cc2ccccc2)C=C(C1c1ccccc1)C(=O)OCC |
Storage | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 5.63 mg/mL (14.37 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.